Ftse Mib
33.834,91
0,00%
DAX
18.325,58
0,77%
S&P 500
5.447,87
-0,31%
NASDAQ
17.496,82
-1,09%
Bitcoin
61.286,62
1,70%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Timber Pharmaceuticals Inc (TMBR) Timber Pharmaceuticals Inc (TMBR) Notizie

TMBR

Timber Pharmaceuticals (TMBR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:TMBR
DataOraFonteTitoloSimboloCompagnia
28/11/202323:21GlobeNewswire Inc.Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE AmericanAMEX:TMBRTimber Pharmaceuticals Inc
18/09/202322:05GlobeNewswire Inc.Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing ComplianceAMEX:TMBRTimber Pharmaceuticals Inc
21/08/202314:00GlobeNewswire Inc.Timber Pharmaceuticals to be Acquired by LEO PharmaAMEX:TMBRTimber Pharmaceuticals Inc
03/07/202322:05GlobeNewswire Inc.Timber Pharmaceuticals Discloses Communication From NYSE AmericanAMEX:TMBRTimber Pharmaceuticals Inc
20/06/202314:00GlobeNewswire Inc.Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
05/06/202314:00GlobeNewswire Inc.Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001AMEX:TMBRTimber Pharmaceuticals Inc
15/05/202322:15GlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
31/03/202322:28GlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
20/03/202313:00GlobeNewswire Inc.Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental DermatologyAMEX:TMBRTimber Pharmaceuticals Inc
24/02/202314:00GlobeNewswire Inc.Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
14/12/202214:30GlobeNewswire Inc.Timber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward OutlookAMEX:TMBRTimber Pharmaceuticals Inc
09/12/202222:05GlobeNewswire Inc.Timber Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsAMEX:TMBRTimber Pharmaceuticals Inc
14/11/202214:00GlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
09/11/202214:20Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TMBRTimber Pharmaceuticals Inc
08/11/202218:09GlobeNewswire Inc.Timber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock SplitAMEX:TMBRTimber Pharmaceuticals Inc
03/11/202213:22GlobeNewswire Inc.Timber Pharmaceuticals Announces Halt of Common Stock Trading  AMEX:TMBRTimber Pharmaceuticals Inc
26/10/202214:40TipRanksAnalysts Are Bullish on These Healthcare Stocks: Biogen (BIIB), Timber Pharmaceuticals (TMBR)AMEX:TMBRTimber Pharmaceuticals Inc
25/10/202214:00GlobeNewswire Inc.Timber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
03/10/202216:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:TMBRTimber Pharmaceuticals Inc
03/10/202215:00GlobeNewswire Inc.Timber Pharmaceuticals Announces $1.3 Million Registered Direct OfferingAMEX:TMBRTimber Pharmaceuticals Inc
14/09/202214:00GlobeNewswire Inc.Timber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital IchthyosisAMEX:TMBRTimber Pharmaceuticals Inc
29/08/202222:05GlobeNewswire Inc.Timber Pharmaceuticals Announces Notification of NYSE American Continued Listing DeficiencyAMEX:TMBRTimber Pharmaceuticals Inc
29/08/202214:00GlobeNewswire Inc.Timber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV CongressAMEX:TMBRTimber Pharmaceuticals Inc
29/08/202212:21TipRanksAnalysts Are Bullish on These Healthcare Stocks: Timber Pharmaceuticals (TMBR), Calithera Bio (CALA)AMEX:TMBRTimber Pharmaceuticals Inc
26/08/202214:00GlobeNewswire Inc.Timber Pharmaceuticals Announces Publication of Results from Phase 2b CONTROL Study of FDA-Designated Breakthrough Therapy TMB-001 in the Journal of the American Academy of DermatologyAMEX:TMBRTimber Pharmaceuticals Inc
15/08/202212:36Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:TMBRTimber Pharmaceuticals Inc
11/08/202223:23Edgar (US Regulatory)Quarterly Report (10-q)AMEX:TMBRTimber Pharmaceuticals Inc
11/08/202223:20GlobeNewswire Inc.Timber Pharmaceuticals Provides Business Update and Announces Second Quarter 2022 Financial ResultsAMEX:TMBRTimber Pharmaceuticals Inc
08/08/202222:05GlobeNewswire Inc.Timber Pharmaceuticals Announces Closing of $8.0 Million Public OfferingAMEX:TMBRTimber Pharmaceuticals Inc
05/08/202222:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)AMEX:TMBRTimber Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:TMBR

La tua Cronologia

BOV
HIWP34
Highwoods Properties
GATE
KEXUSDT
KIRA Network
COIN
HSCCUST
HANSANCOIN
NASDAQ
AAWNXXX
Bmo Harris Bank Na Point...
BIT
1TYRES
Nokian Renkaat Oyj
BIT
P1WVF0
NLBNPIT1WVF0 20240920 2.5
EU
CFHBF
Credit Agricole Financem...
TG
8ET
Sf Real Estate Investment
USOTC
SNNHF
Kingwell (PK)
KOSPI
011000
Gene One Life Science
BOV
K1EL34R
Kellanova
AMEX
NAIL
Direxion Daily Homebuild...
USOTC
WDGNF
Widgie Nickel (PK)
KOSDAQ
049630
Jaeyoung Solutec
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network